Notice ID: b7d0d6314df04550aed5f9ebac03e3fdAward NoticeAwarded
6505--RADIOPHARMACEUTICALS FOR DIAGNOSTIC AND THERAPEUTIC PROCEDURES
Awarded on October 1, 2022. Full description on SAM.gov.
Awarded tounder 36C25923D0003 (source: SAM.gov award notice)• $0
Overview
- Posted
- October 1, 2022
- Notice type
- Award Notice
Notice details
- Last updated
- Dec 4, 2025
- Award date
- Oct 1, 2022
- Award amount (SAM.gov award notice)
- $0
Identifiers
- Solicitation number
- 36C25922Q0711
- Notice ID
- b7d0d6314df04550aed5f9ebac03e3fd
- Award number (PIID)
- 36C25923D0003
Description
The purpose of Amendment 0001 is to provide a Questions and Answers document.
Award Overview
Award Number
36C25923D0003
Award Amount (SAM.gov award notice)
$0
Award Date
Oct 1, 2022
Awardee
Awardee UEI
GY8NMUZQXVS7
Awardee CAGE Code
4B862
Original Solicitation
Notice ID: b7d0d6314df04550aed5f9ebac03e3fd
Posted Date: Oct 1, 2022
Original Response Deadline: Not specified
Task Orders Under This IDV
Top 10 by total obligated
- $476.8KSigned Dec 5, 2024
- $465.5KSigned Aug 22, 2024
- $444.4KSigned Oct 1, 2026
- $435.7KSigned Oct 1, 2025
- $429.9KSigned Dec 16, 2025
- $423.9KSigned Oct 1, 2024
- $417.7KSigned Oct 1, 2023
- $411.1KSigned Oct 1, 2022
- $368.6KSigned Nov 9, 2023
More From This Vendor
Top 5 most recent
- $444.5KSigned Oct 1, 2026
- $377.9KSigned Oct 1, 2026
- $444.4KSigned Oct 1, 2026
- $358.2KSigned Sep 30, 2026
- $279.8KSigned Sep 29, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C25922Q0711- Combined Synopsis
- Awarded
This opportunity has been awarded.
- 2×Combined SynopsisAug 30, 2022
6505--RADIOPHARMACEUTICALS FOR DIAGNOSTIC AND THERAPEUTIC PROCEDURES
- AwardedCurrentOct 1, 2022
6505--RADIOPHARMACEUTICALS FOR DIAGNOSTIC AND THERAPEUTIC PROCEDURES
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Sources Sought Notice - General Radioisotopes (Diagnostic & Therapeutic) Disclaimer: This Request for Information (RFI) is issued solely for market research information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Responses to this notice are NOT offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. Information Requested from Industry: In response to the Sources Sought, interested Contractors shall submit the following information and any Capabilities/Qualifications Statement to include but not limited to an overview of proposed solution(s) and a description of the product your company possesses in accordance with the draft Statement of Work (SOW) / general requirement and deliverables list. Responses to market research questions shall be submitted. If this information is not provided, then it will be assumed the entire requirement cannot be met. Confirmation that interested party can meet the required timelines listed in draft SOW. Description of Requirement: The Department of Veterans Affairs, Veterans Health Administration (VHA), Network Contracting Office 19 (NCO 19) is conducting a market survey and is seeking potential sources for unit dose radiopharmaceuticals, radioactive sources, and supplies for diagnostic imaging exams and quality assurance procedures (brand name or equal) for the Salt Lake City VA Medical Center. This Sources Sought Notice is issued for information and planning purposes only. This is not a solicitation or a request for proposal and shall not be construed as an obligation or commitment by the Government. An award will not be made on any offers submitted in response to this notice, and it shall not be implied the Government is committed to providing any solicitation or award following this notice. The Government will not pay for any information received in response to this request, nor will the Government compensate a respondent for any costs incurred in developing the information provided. Please note that due to the degradation properties of the requested radioisotopes any potential awardee must comply with the delivery requirements contained in the attached statement of work and provide proof that the calibrated date and time constraints can be met. Due to radiological properties and hazardous nature of requested products, any potential awardee must hold all applicable licensing and management systems as outlined in the draft SOW. If you can provide, please answer the following questions: Vendor Name: Vendor POC: Vendor SAM ID #: Vendor business size status (SDVOSB, 8(a), small/large business): Estimated delivery/lead time: Manufacturer of the item(s): a) Name: b) Place of manufacture end product: c) Size status: Provide a list of Authorized distributors (if applicable): GSA/FSS Schedule contract # (if applicable): Y/N _____ Does not exceed 1,300 employees; (NAICS 325412 - must be verifiable thru the System for Award Management). If yes, how many employees? _____ Y/N _____ Is primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied; Y/N _____ Takes ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice (identify how this occurs); **drop shipping is an acceptable way to take possession** and Y/N _____ Will supply the end item of a small business manufacturer, processor or producer made in the United States, or obtains a waiver of such requirement pursuant to paragraph (b)(5) CFR 121.406. NOTE: If you company is a distributor, of requested products, from a vendor other than yourself please provide a copy of the Authorized Distributor letter or Letter of Authorization (LOA) from that manufacturer. Response Instructions: Do not provide more than 8 pages, including cover letter page. Submit your response via email to mark.holland@va.gov Submit your response NLT 10:00 (MST) on Thursday, November 12, 2026; Mark your response as Proprietary Information if the information is considered business sensitive. VA has identified the appropriate North American Industry Classification System (NAICS) Code as 325412 (Pharmaceutical Preparation Manufacturing) with a Small Business size of 1,300 Employees. (End of Sources Sought) | 97% | Market Research | 11/12/2026 |
83% | Awarded | Open | |
83% | Awarded | Open | |
83% | Awarded | Open | |
Sources sought notice for VISN 2 Downstate General Radiopharmaceuticals. | 82% | Market Research | 11/17/2026 |
Additional Details
Solicitation Number
36C25922Q0711
Archive Date
Oct 31, 2022
Office Address
Greenwood Village, CO, 80111